S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
Tesla cuts US prices for 3 of its electric vehicle models after a difficult week
A coffee roastery in Finland has launched an AI-generated blend. The results were surprising
Autoworkers union celebrates breakthrough win in Tennessee and takes aim at more plants in the South
The House votes for possible TikTok ban in the US, but don't expect the app to go away anytime soon
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
New York lawmakers pass $237 billion budget with policies to jump-start housing market
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
Tesla cuts US prices for 3 of its electric vehicle models after a difficult week
A coffee roastery in Finland has launched an AI-generated blend. The results were surprising
Autoworkers union celebrates breakthrough win in Tennessee and takes aim at more plants in the South
The House votes for possible TikTok ban in the US, but don't expect the app to go away anytime soon
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
New York lawmakers pass $237 billion budget with policies to jump-start housing market
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
Tesla cuts US prices for 3 of its electric vehicle models after a difficult week
A coffee roastery in Finland has launched an AI-generated blend. The results were surprising
Autoworkers union celebrates breakthrough win in Tennessee and takes aim at more plants in the South
The House votes for possible TikTok ban in the US, but don't expect the app to go away anytime soon
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
New York lawmakers pass $237 billion budget with policies to jump-start housing market
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
Tesla cuts US prices for 3 of its electric vehicle models after a difficult week
A coffee roastery in Finland has launched an AI-generated blend. The results were surprising
Autoworkers union celebrates breakthrough win in Tennessee and takes aim at more plants in the South
The House votes for possible TikTok ban in the US, but don't expect the app to go away anytime soon
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
New York lawmakers pass $237 billion budget with policies to jump-start housing market

MacroGenics (MGNX) Earnings Date, Estimates & Call Transcripts

$15.61
-0.46 (-2.86%)
(As of 04/19/2024 ET)

Earnings Summary

Upcoming
Earnings Date
May. 14Estimated
Actual EPS
(Mar. 7)
-$0.75 Missed By -$0.49
Consensus EPS
(Mar. 7)
-$0.26
Skip Charts & View Estimated and Actual Earnings Data

MGNX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

MGNX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

MacroGenics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20241($0.54)($0.54)($0.54)
Q2 20241($0.57)($0.57)($0.57)
Q3 20241($0.59)($0.59)($0.59)
Q4 20241($0.62)($0.62)($0.62)
FY 20244($2.32)($2.32)($2.32)

MGNX Earnings Date and Information

MacroGenics last posted its earnings data on March 7th, 2024. The biopharmaceutical company reported ($0.75) EPS for the quarter, missing analysts' consensus estimates of ($0.26) by $0.49. The business earned $10.72 million during the quarter, compared to analysts' expectations of $25.70 million. MacroGenics has generated ($0.16) earnings per share over the last year (($0.16) diluted earnings per share). Earnings for MacroGenics are expected to grow in the coming year, from ($2.70) to ($1.54) per share. MacroGenics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 14th, 2024 based off prior year's report dates.

MacroGenics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/14/2024
Estimated)
------- 
3/7/2024Q4 2023($0.26)($0.75)($0.49)($0.75)$25.70 million$10.72 million    
11/6/2023Q3 2023($0.03)($0.52)($0.49)($1.32)$54.80 million$10.40 million
8/9/2023Q2 2023($0.52)($0.36)+$0.16($1.64)$27.06 million$13.14 million
5/9/2023Q1 2023$1.07($0.61)($1.68)($0.61)$129.65 million$24.50 million
3/15/2023Q4 2022($0.30)$0.21+$0.51$0.21$75.40 million$73.10 million
11/3/2022Q3 2022($0.49)($0.40)+$0.09($0.40)$22.74 million$41.73 million
8/8/2022Q2 2022($0.97)($0.67)+$0.30($0.67)$14.59 million$26.01 million
5/3/2022Q1 2022($0.84)($1.08)($0.24)($1.08)$17.20 million$11.10 million    
2/24/2022Q4 2021($0.83)($0.95)($0.12)($0.95)$19.83 million$14.15 million    
11/2/2021Q3 2021($0.63)($0.86)($0.23)($0.86)$39.56 million$15.66 million    
7/29/2021Q2 2021($0.28)($0.66)($0.38)($0.66)$35.55 million$30.76 million    
4/29/2021Q1 2021($0.53)($0.90)($0.37)($0.90)$31.16 million$16.88 million  

MacroGenics Earnings - Frequently Asked Questions

When is MacroGenics's earnings date?

MacroGenics has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 14th, 2024 based off last year's report dates. Learn more on MGNX's earnings history.

Did MacroGenics beat their earnings estimates last quarter?

In the previous quarter, MacroGenics (NASDAQ:MGNX) missed the analysts' consensus estimate of ($0.26) by $0.49 with a reported earnings per share (EPS) of ($0.75). Learn more on analysts' earnings estimate vs. MGNX's actual earnings.

How can I listen to MacroGenics's earnings conference call?

The conference call for MacroGenics's latest earnings report can be listened to online. Listen to Conference Call

How can I read MacroGenics's conference call transcript?

The conference call transcript for MacroGenics's latest earnings report can be read online. Read Transcript

How much revenue does MacroGenics generate each year?

MacroGenics (NASDAQ:MGNX) has a recorded annual revenue of $58.75 million.

How much profit does MacroGenics generate each year?

MacroGenics (NASDAQ:MGNX) has a recorded net income of -$9.06 million. MGNX has generated -$0.16 earnings per share over the last four quarters.

What is MacroGenics's EPS forecast for next year?

MacroGenics's earnings are expected to grow from ($2.70) per share to ($1.54) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:MGNX) was last updated on 4/21/2024 by MarketBeat.com Staff

From Our Partners